GRAVES JEFFREY A 4

What Happened
Jeffrey A. Graves, a director of Integra LifeSciences Holdings Corp (IART), received a grant of 17,700 restricted stock units (RSUs) on May 7, 2026. The Form 4 reports the award as a derivative acquisition at $0.00 per unit (total reported value $0) — an equity compensation grant rather than a market purchase or sale.

Key Details

• Transaction date: May 7, 2026; Form filed May 11, 2026.
• Grant: 17,700 RSUs (reported as derivative acquisition, $0.00 per unit).
• Post-transaction shares owned: not specified in the filing.
• Footnotes: F1 — RSUs granted under the company’s 2003 Equity Incentive Plan; each RSU represents a contingent right to one share. F2 — RSUs vest in full on the one-year anniversary of the grant (May 7, 2027).
• No 10b5-1 plan, tax withholding, or late-filing flag noted in the filing.

Context
RSUs are a common form of executive/director compensation: they convert into shares only if vesting conditions are met (here, time-based vesting after one year). Because this is an award (not an open-market purchase or sale), it’s a compensation event and does not by itself signal a director buying or selling stock.